TSXV Conditional Approval: The Smart Way to Invest in Pharma
TSXV conditional approval is a crucial step for investors in the pharma sector. Discover what it means for Harmony and Vimy Pharma.
FDA Approval Ketamine: Proven Milestone for Depression Treatment
FDA approval ketamine marks a significant milestone for treatment of suicidal depression, offering hope for patients.
FDA Accelerated Approval: INOVIO’s Proven VOCERYQ Breakthrough
FDA accelerated approval is a game changer for INOVIO’s VOCERYQ, reducing RRP surgeries effectively.
Anti-cancer drug prices drop with proven savings
Anti-cancer drug prices have seen significant reductions, with cuts over 90% on 543 formulations under TMR.
Biogen Inc. stock news: The Best Proven Insights
Biogen Inc. stock news provides the latest updates and insights on BIIB’s market performance and financial health.
Are Injectable Aesthetic Products the Best Choice for You?
Injectable aesthetic products are gaining popularity. Discover if they are the right option for your beauty needs.
Cancer medicine prices: Clear drop of up to 70% expected
Cancer medicine prices are set to drop significantly, with retail prices expected to decrease by up to 70% from November 9.
Is Diarrhea Treatment for Adolescents Safe and Proven?
Diarrhea treatment adolescents has gained expanded approval for effectiveness and safety. Discover the latest insights on Hidrasec’s benefits.
Cancer drugs price cap: Clear benefits for patients
Cancer drugs price cap introduces potential savings on medications for patients, ensuring affordability and accessibility.
Bajaj stake acquisition: Is it the best move for Mitshi India?
Bajaj stake acquisition could reshape Mitshi India’s future in pharma.